| 1 |
Z. B. Zhang, Z. G. Shen, J. X. Wang, H. X. Zhang, H. Zhao, J. F. Chen, and J. Yun, Micronization of silybin by the emulsion solvent diffusion method, Int. J. Pharm., 376, 116 (2009).
DOI
|
| 2 |
K. A. Shah, A. A. Date, M. D. Joshi, and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery, Int. J. Pharm., 345, 163 (2007).
DOI
|
| 3 |
M. Moinard-Checot, Y. Chevalier, S. Briancon, L. Beney, and H. Fessi, Mechanism of nanocapsules formation by the emulsion-diffusion process, J. Colloid Interface Sci., 317, 458 (2008).
DOI
ScienceOn
|
| 4 |
J. Jung and M. Perrut, Particle design using supercritical fluids: literature and patent survey, J. Supercrit. Fluids, 20, 179 (2001).
DOI
ScienceOn
|
| 5 |
R. Jagannathan, G. Irvin, T. Blanton, and S. Jagannathan, Organic nanoparticles: preparation, selfassembly, and properties, Adv, Funct. Mater, 16, 747 (2006).
DOI
ScienceOn
|
| 6 |
C. Gomez-Gaete, N. Tsapis, M. Besnard, A. Bochot, and E. Fattal, Encapsulation of dexamethasone into biodegradable polymeric nanoparticles, Int. J. Pharm., 331, 153 (2007).
DOI
ScienceOn
|
| 7 |
S. A. Wissing, O. Kayser, and R. H. Muller, Solid lipid nanoparticles for parenteral drug delivery, Adv. Drug. Deliv. Rev., 56, 1257 (2004).
DOI
ScienceOn
|
| 8 |
D. Quintanar-Guerrero, E. AlIeman, H. Fessi, and E. Doelker, Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers, Drug Dev. Ind. Pharm., 24, 1113 (1998).
DOI
ScienceOn
|
| 9 |
H. S. Tan and W. R. Pfister, Pressure-sensitive adhesives for transdermal drug delivery systems, PSTT, 2(2), 60 (1999).
|
| 10 |
C. Ramachandran and D. Fleisher, Transdermal delivery of drugs for the treatment of bone diseases, Adv. Drug Deliv. Rev.. 42, 197 (2000).
DOI
ScienceOn
|
| 11 |
R. H. Mueller, K. Maeder, and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art, Eur. J. Pharm. Biopharm., 50, 161 (2000).
DOI
ScienceOn
|
| 12 |
H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int. J. Pharm., 55, R1 (1989).
DOI
ScienceOn
|
| 13 |
B. Mishra, B. B. Patel, and S. Tiwari, Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery, Nanomedicine: Nanotechnology, Biology, and Medicine, 6, 9 (2010).
DOI
ScienceOn
|
| 14 |
E. Reverchon, G. D. Porta, and R. Taddeo, Solubility and micronization of griseofulvin in supercritical CHF3, Ind. Eng. Chem. Res., 34, 4087 (1995).
DOI
ScienceOn
|
| 15 |
El-S. Khafagy, M. Morishita, Y. Onuki, and K. Takayama, Current challenges in non-invasive insulin delivery systems: a comparative review, Adv. Drug Deliv. Rev.. 59, 1521 (2007).
DOI
ScienceOn
|
| 16 |
J. A. Subramony, A. Sharma, and J. B. Phipps, Microprocessor controlled transdermal drug delivery, Int. J. Pharm., 317, 1 (2006).
DOI
ScienceOn
|
| 17 |
B. Jiang, L. Hu, C. Gao, and J. Shen, Ibuprofenloaded nanoparticles prepared by a co-precipitation method and their release properties, Int. J. Pharm., 304, 220 (2005).
DOI
ScienceOn
|
| 18 |
X. Chen, T. J. Young, M. Sarkari, R. O. Williams, and K. P. Johnston, Preparation of cyclosporine a nanoparticles by evaporative precipitation into aqueous solution, Int. J. Pharm., 242, 3 (2002).
DOI
ScienceOn
|
| 19 |
S. Goto, M. Kawata, T. Suzuki, N. S. Kim, and C. Ito, Preparation and evaluation of eudragit gels. I: eudragit organogels containing drugs as rectal sustainedrelease preparations, J. Pharm. Sci., 80, 958 (1991).
DOI
|
| 20 |
M. M. Badrana, J. Kuntsche, and A. Fahra, Skin penetration enhancement by a microneedle device ( ) in vitro: dependency on needle size and applied formulation, Eur. J. Pharm. Sci., 36, 511 (2009).
DOI
ScienceOn
|
| 21 |
P. Santoianni, M. Nino, and G. Calabro, Intradermal drug delivery by low frequency sonophoresis (25 kHz), Dermatol. Online J., 10, 24 (2004).
|
| 22 |
A. Arellano, S. Santoyo, C. Martin, and P. Ygartua, Influence of propylene glycol and isopropyl myristate on in vitro percutaneous penetration of diclofenac sodium from carbopol gel, Eur. J. Pharm. Sci., 7, 129 (1999).
DOI
ScienceOn
|
| 23 |
M. C. Jones, P. Tewari, C. Blei, K. Hales, D. J. Pochan, and J. C. Leroux, Self-assembled nanocages for hydrophilic guest molecules, J. Am. Chem. Soc., 128, 14599 (2006).
DOI
ScienceOn
|
| 24 |
T. Penzes, I. Csoka, and I. Eros, Rheological analysis of the structural properties effecting the percutanneous absorption and stability in pharmaceutical organogels, Rheol. Acta, 43, 457 (2004).
DOI
ScienceOn
|
| 25 |
L. Kang, X. Y. Liu, P. D. Sawant, P. C. Ho, Y. W. Chan, and S. Y. Chan, SMGA gels for the skin permeation of haloperidol, J. Control. Release, 106, 88 (2005).
DOI
ScienceOn
|
| 26 |
U. S. Patent 6,632,843 (2003).
|
| 27 |
S. Murdan, G. Gregoriadis, and A. T. Florence, Non-ionic surfactant based organogels incorporating niosomes, S.T.P. Pharm. Sci., 6, 44 (1996).
|
| 28 |
J. H. Park, S. O. Choi, S. M. Seo, Y. B. Choy, R. Mark, and A. Prausnitz, Microneedle roller for transdermal drug delivery, Eur. J. Pharm. Biopharm., 76, 282 (2010).
DOI
ScienceOn
|
| 29 |
N. Katz, D. Shapiro, T. Herrmann, J. Kost, and L. Custer, Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device, Anesth. Analg., 98, 371 (2004).
|
| 30 |
J. Chen, K. D. Wise, J. F. Hetke, and S. C. Bledsoe, A multichannel neural probe for selective chemical delivery at the cellular level, IEEE Trans. Biomed. Eng., 44, 760 (1997).
DOI
ScienceOn
|
| 31 |
W. G. Cho, M. J. Rang, Y. S. Song, Y. H. Lim, and H. W. Park, Enhanced transdermal delivery of vitamin C derivative using gel patch with flexible thin layer battery, J. Soc. Cosmet. Sci., Kor., 33(1), 23 (2007).
|
| 32 |
U. S. Patent 28,789 (2002).
|
| 33 |
N. Jibry and S. Murdan, In vivo investigation, in mice and man, into the irritation potential of novel amphiphilogels being studied as transdermal drug carriers, Eur. J. Pharm. Biopharm., 58, 107 (2004).
DOI
ScienceOn
|
| 34 |
R. C. Robinson, Plastibase, a hydrocarbon gel ointment base, Bull. Sch. Med. Univ. Md., 40, 86 (1955).
|
| 35 |
U. S. Patent 6,306,383 (2001).
|
| 36 |
S. B. Hoffman, A. R. Yoder, and L. A. Trepanier, Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats, J. Vet. Pharmacol. Ther., 25, 189 (2002).
DOI
ScienceOn
|
| 37 |
S. Mitragotri and J. Kost, Low-frequency sonophoresis, Adv. Drug Deliv. Rev., 56, 589 (2004).
DOI
ScienceOn
|
| 38 |
D. Bommannan, H. Okuyama, P. Stauffer, and R. H. Guy, The use of high-frequency ultrasound to enhance transdermal drug delivery, Pharm. Res., 9, 559 (1992).
DOI
ScienceOn
|
| 39 |
S. Mitragotri, Synergistic effect of enhancers for transdermal drug delivery, Pharm. Res., 17, 1354 (2000).
DOI
ScienceOn
|
| 40 |
R. Z. Aboofazeli, H. Zia, and T. E. Needham, Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement, Drug Deliv., 9, 239 (2002).
DOI
ScienceOn
|
| 41 |
S. Bhatnagar and S. P. Vyas, Organogel-based systems for transdermal delivery of propranolol, J. Microencapsul., 2, 431 (1994).
|
| 42 |
S. H. Jeong, W. G. Cho, J. K. Choi, and J. P. Ryoo, A systematic approach to cosmetic patch development, Cosmet. Toilet., 116(1), 39 (2001).
|
| 43 |
J. Frelichowska, M. Bolzinger, J. Valour, H. Mouaziz, J. Pelletier, and Y. Chevalier, Pickering W/O emulsions: drug release and tropical delivery, Int. J. Pharm., 368, 7 (2009).
DOI
|
| 44 |
S. A. Fotinos, Handbook of Cosmetic Science and Technology, eds. A. O. Barel, M. Paye, and H. I. Maibach, 233, Marcel Dekker Inc., New York (2001).
|
| 45 |
J. Frelichowska, M. Bolzinger, J. Pelletier, J. Valour, and Y. Chevalier, Tropical delivery of lipophilic drugs from O/W pickering emulsions, Int. J. Pharm., 371, 56 (2009).
DOI
|
| 46 |
E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, and C. Puglia, Cubosome dispersions as delivery systems for percutaneous administration of indomethacin, Pharm. Res., 22, 2163 (2005).
DOI
ScienceOn
|
| 47 |
L. B. Lopes, D. A. Ferreira, D. Paula, M. T. J. Garcia, J. A. Thomazini, M. C. A. Fantini, and M. V. L. B. Bentley, Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A, Pharm. Res., 23, 1332 (2006).
DOI
ScienceOn
|
| 48 |
C. Nastruzzi and R. Gambari, Antitumor activity of (trans)dermally delivered aromatic tetra-amidines, J. Control Release, 29, 53 (1994).
DOI
ScienceOn
|
| 49 |
F. Dreher, P. Walde, P. Walther, and E. Wehrli, Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport, J. Control. Release, 45, 131 (1997).
DOI
ScienceOn
|
| 50 |
L. B. Lopes, J. L. C. Lopes, D. C. R. Oliveira, J. A. Thomazini, M. T. J. Garcia, M. C. A. Fantini, J. H. Collett, and M. V. L. B. Bentley, Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery, Eur. J. Pharm. Biopharm.. 63, 146 (2006).
DOI
ScienceOn
|
| 51 |
L. B. Lopes, F. F. F. Sperettaa, and M. V. L. B. Bentley, Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems, Eur. J. Pharm. Sci., 32, 209 (2007).
DOI
ScienceOn
|
| 52 |
M. Cohen-Avrahami, A. Aserin, and N. Garti, HII mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac, Colloid Surf. B, 77, 131 (2010).
DOI
ScienceOn
|
| 53 |
J. Bender, M. B. Ericson, N. Merclin, V. Ianie, A. Rosen, S. Engstrom, and J. Moan, Lipid cubic phases for improved topical drug delivery in photodynamic therapy, J. Control. Release, 106, 350 (2005).
DOI
ScienceOn
|
| 54 |
H. Willimann and P. L. Luisi, Lecithin organogels as matrix for transdermal transport of drugs, Biochem. Biophys. Res. Commun., 177, 897 (1991).
DOI
ScienceOn
|
| 55 |
H. Willimann, P. Walde, P. L. Luisi, A. Gazzaniga, and F. Stroppolo, Lecithin organogels as matrix for transdermal transport of drugs, J. Pharm. Sci., 81, 871 (1992).
DOI
|
| 56 |
R. Kumar and O. P. Katare, Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review, AAPS Pharm. Sci. Tech.. 6, e298 (2005).
DOI
|
| 57 |
S. Y. Lin, C. J. Ho, and M. J. Li, Precision and reproducibility of temperature response of a thermo- responsive membrane embedded by binary liquid crystals for drug delivery, J. Control. Release, 73(2,3), 293 (2001).
DOI
|
| 58 |
S. Y. Lin, H. L. Lin, and M. J. Li, Manufacturing factors affecting the drug delivery function of thermo- responsive membrane prepared by adsorption of binary liquid crystals, Eur. J. Pharm. Sci., 17(3), 153 (2002).
DOI
ScienceOn
|
| 59 |
Y. A. Shchipunov and E. V. Shumilina, Lecithin bridging by hydrogen bonds in the organogel, Mater. Sci. Eng., C, Biomim. Supramol. Syst., 3(1), 43 (1995).
DOI
ScienceOn
|
| 60 |
R. Scartazzini and P. L. Luisi, Organogels from lecithins, J. Phys. Chem., 92, 829 (1988).
DOI
|
| 61 |
D. I. Nesseem, Formulation and evaluation of itraconazole via liquid crystal for topical delivery system, J. Pharm. Biomed. Anal., 26(3), 387 (2001).
DOI
ScienceOn
|
| 62 |
D. S. Mou, H. B. Chen, D. R. Du, C. W. Mao, J. L. Wan, H. B. Xu, and X. L. Yang, Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs, Int. J Pharm., 353, 270 (2008).
DOI
ScienceOn
|
| 63 |
C. C. Muller-Goymann, Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration, Eur. J. Pharm. Biopharm., 58(2), 343 (2004).
DOI
ScienceOn
|
| 64 |
W. K. Fong, T. Hanley, and B. J. Boyd, Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo, J. Control. Release, 135, 218 (2009).
DOI
ScienceOn
|
| 65 |
D. Libster, A. Aserin, E. Wachtel, G. Shoham, and N. Garti, An  liquid crystal-based delivery system for cyclosporin A: physical characterization, J. Colloid Interface Sci., 308(2), 514 (2007).
DOI
ScienceOn
|
| 66 |
C. Guo, J. Wang, F. Cao, R. J. Lee, and G. Zhai, Lyotropic liquid crystal systems in drug delivery, Drug Discov. Today, 15, 1032 (2010).
DOI
ScienceOn
|
| 67 |
N. Moussaoui, M. Cansell, and A. Denizot, Marinosomes marine lipid-based liposomes: physical characterization and potential applications in cosmetics, Int. J. Pharm., 242, 361 (2002).
DOI
ScienceOn
|
| 68 |
P. F. Lim, X. Y. Liu, L. Kang, P. C. Ho, Y. W. Chan, and S. Y. Chan, Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol, Int. J. Pharm., 311, 157 (2006).
DOI
|
| 69 |
S. Pisal, V. Shelke, K. Mahadik, and S. Kadam, Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride, AAPS Pharm. Sci. Tech., 5, e63 (2004).
DOI
|
| 70 |
S. Z. Mohammady, M. Pouzot, and R. Mezzenga, Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment, Biophys. J., 96(4), 1537 (2009).
DOI
ScienceOn
|
| 71 |
V. B. Patravale and S. D. Mandawgade, Novel cosmetic delivery systems: an application update, Int. J. Cosmet. Sci., 30, 19 (2008).
DOI
ScienceOn
|
| 72 |
K. Stanzl, L. Zastrow, J. Rdding, and C. Artmann, The effectiveness of molecular oxygen in cosmetic formulation, Int. J. Cosmet. Sci., 18(3), 137 (1996).
|
| 73 |
N. Jain, B. P. Gupta, N. Thakur, R. Jain, J. Banweer, D. K. Jain, and S. Jain, Phytosome: a novel drug delivery system for herbal medicine, Int. J. Pharm. Sci. and Drug Res., 2(4), 224 (2010).
|
| 74 |
P. Schurtenberger, R. Scartazzini, L. J. Magid, M. E. Leser, and P. L. Luisi, Structural and dynamic properties of polymer-like reverse micelles, J. Phys. Chem., 94, 3695 (1990).
DOI
|
| 75 |
D. Grace, J. Rogers, K. Skeith, and K. Anderson, Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee, J. Rheumatol., 26, 2659 (1999).
|
| 76 |
F. Dreher, P. Walde, P. Walter, and E. Wehrli, Interaction of a lecithin microemulasion gel with human stratum corneum and its effect on transdermal transport, J. Control. Release, 45, 131 (1997).
DOI
ScienceOn
|
| 77 |
G. Nicolaos, S. Crauste-Manciet, R. Farinotti, and D. Brossard, Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion, Int. J. Pharm., 263, 165 (2003).
DOI
|
| 78 |
D. D. Lasic, Sterically stabilized liposomes in cancer therapy and gene delivery, Curr. Opin. Mol. Ther., 1, 177 (1999).
|
| 79 |
R. Peschka, C. Dennehy, and Jr. F. C. Szoka, A simple in-vitro model to study the release kinetics of liposomes encapsulated material, J. Control. Release, 56, 41 (1998).
DOI
|
| 80 |
L. Kang, X. Y. Liu, P. D. Sawant, P. C. Ho, Y. W. Chan, and S. Y. Chan, SMGA gels for the skin permeation of haloperidol, J. Control. Release, 106, 88 (2005).
DOI
ScienceOn
|
| 81 |
N. G. Kang, J. M. Lim, M. Y. Chang, S. G. Park, W. G. Cho, and Y. S. Choi, Modified superoxide dismutase for cosmeceuticals, IFSCC Magazine, 8(2), 87 (2005).
|
| 82 |
Y. A. Shchipunov and E. V. Shumilina, Lecithin organogels: role of polar solvent and nature of intermolecular interactions, Colloid J., 58, 117 (1996).
|
| 83 |
J. M. Lim, M. Y. Chang, S. G. Park, N. G. Kang, Y. S. Song, Y. S. Kang, and W. G. Cho, The penetration enhancement and lipolytic effects of TATGKH, both in vitro, ex-vivo, and in-vivo, IFSCC Magazine, 7(2), 103 (2004).
|
| 84 |
H. Cesur, I. Rubinstein, A. Pai, and H. Onyuksel, Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer, Nanomedicine, 5(2), 178 (2009).
DOI
ScienceOn
|
| 85 |
D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, Pharmacol Rev., 51, 691 (1999).
|
| 86 |
J. M. Lim, M. Y. Chang, S. G. Park, N. G. Kang, Y. S. Song, Y. H. Lee, Y. C. Yoo, W. G. Cho, S. Y. Choi, and S. H. Kang, Penetration enhancement in mouse skin and lipolysis in adipocytes by TATGKH, a mew cosmetic ingredient, J. Comet. Sci., 54, 483 (2003).
|
| 87 |
S. K. Sahoo and V. Labhasetwar, Nanotech approaches to drug delivery and imaging, Drug Discov. Today, 8, 1112 (2003).
DOI
ScienceOn
|
| 88 |
T. K. Jain, J. Richey, M. Strand, D. L. Leslie- Pelecky, C. A. Flask, and V. Labhasetwar, Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging, Biomaterials. 29, 4012 (2008).
DOI
ScienceOn
|
| 89 |
Z. Chunfu, C. Jinquan, Y. Duanzhi, W. Yongxian, F. Yanlin, and T. Jiaju, Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy, Appl. Radiat. Isot., 61, 1255 (2004).
DOI
ScienceOn
|
| 90 |
P. K. Jain, I. H. El-Sayed, and M. A. El-Sayed, Au nanoparticles target cancer, Nano, Today, 2, 18 (2007).
|
| 91 |
C. H. Purdon, C. G. Azzi, J. Zhang, E. W. Smith, and H. I. Maibach, Penetration enhancement of transdermal delivery-current permutations and limitations, Crit. Rev. Ther. Drug Carrier. Syst., 21, 97 (2004).
DOI
|
| 92 |
D. Moinard-Checot, Y. Chevalier, S. Briancon, L. Beney, and H. Fessi, Mechanism of nanocapsules formation by the emulsion diffusion process, J. Colloid Interface Sci., 317, 458 (2008).
DOI
ScienceOn
|
| 93 |
P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi, Solid lipid nanoparticles for targeted brain drug delivery, Adv. Drug Deliv. Rev., 59, 454 (2007).
DOI
ScienceOn
|
| 94 |
I. I. Slowing, J. L. Vivero-Escoto, C. Wu, and V. S. Li, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers, Adv. Drug Deliv. Rev., 60, 1278 (2008).
DOI
ScienceOn
|
| 95 |
J. Pardeike, A. Hommoss, and R. H. Muller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm., 366, 170 (2009).
DOI
ScienceOn
|
| 96 |
G. Cevc and U. Vierl, Nanotechnology and transdermal route: a state of the art review and critical appraisal, J. Control. Release, 141, 277 (2010).
DOI
ScienceOn
|
| 97 |
P. Karande, A. Jain, and S. Mitragotri, Discovery of transdermal penetration enhancers by high-throughput screening, Nat. Biotechnol., 22, 192 (2004).
DOI
ScienceOn
|
webmaster
